Saman Sargolzaei

Dr. Saman Sargolzaei

Program Chair of Artificial Intelligence, Belhaven University, Jackson, California, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017
Verified
Conference Paper
Closed access
TATareq Ahram
Tareq Ahram
Arman SargolzaeiArman Sargolzaei
Arman Sargolzaei
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
JDJeff Daniels
Jeff Daniels
BABen Amaba
Ben Amaba
Digital world has produced efficiencies, new innovative products, and close customer relationships globally by the effective use of mobile, IoT (Internet of Things), social media, analytics and cloud technology to generate models for better decisions. Blockchain is recently introduced and revolutionizing the digital world bringing a new perspective to security, resiliency and efficiency of systems. While initially popularized by Bitcoin, Blockchain is much more than a foundation for crypto currency. It offers a secure way to exchange any kind of good, service, or transaction. Industrial growth increasingly depends on trusted partnerships; but increasing regulation, cybercrime and fraud are inhibiting expansion. To address these challenges, Blockchain will enable more agile value chains, faster product innovations, closer customer relationships, and quicker integration with the IoT and cloud technology. Further Blockchain provides a lower cost of trade with a trusted contract monitored without intervention from third parties who may not add direct value. It facilitates smart contracts, engagements, and agreements with inherent, robust cyber security features. This paper is an effort to break the ground for presenting and demonstrating the use of Blockchain technology in multiple industrial applications. A healthcare industry application, Healthchain, is formalized and developed on the foundation of Blockchain using IBM Blockchain initiative. The concepts are transferable to a wide range of industries as finance, government and manufacturing where security, scalability and efficiency must meet.

27 July 2017 in IEEE Access
Verified
Journal Article
Open access
Arman SargolzaeiArman Sargolzaei
Arman Sargolzaei
KYKang K. Yen
Kang K. Yen
MAMohamed N. Abdelghani
Mohamed N. Abdelghani
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
BCBogdan Carbunar
Bogdan Carbunar
Industrial control systems are distributed hierarchical networks that share information via an assortment of communication protocols. Such systems are vulnerable to attacks that can cause disastrous consequences. This article focuses on time delay switch (TDS) attacks and shows that cryptographic solutions are ineffective in recovering from the denial of service component of TDS attacks. Therefore, a cryptography-free TDS recovery (CF-TDSR) communication protocol enhancement is developed that leverages adaptive channel redundancy techniques and a novel state estimator, to detect and recover from the destabilizing effects of TDS attacks. Simulation results are conducted to prove that CF-TDSR ensures the control stability of linear time invariant systems and to show the efficacy of CF-TDSR against attacks deployed on multi-area load frequency control components of a distributed power grid.

1 January 2015 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
MCMercedes Cabrerizo
Mercedes Cabrerizo
MGMohammed Goryawala
Mohammed Goryawala
AEAnas Salah Eddin
Anas Salah Eddin
MAMalek Adjouadi
Malek Adjouadi

1 January 2017 in Journal of Advances in Information Technology
Verified
Journal Article
Open access
DMDallas Lockheed Martin
Dallas Lockheed Martin
JDJeff Daniel
Jeff Daniel
Arman SargolzaeiArman Sargolzaei
Arman Sargolzaei
MAMohammed Abdelghani
Mohammed Abdelghani
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
BABen Amaba
Ben Amaba

16 November 2020 in Frontiers in Nanotechnology
Verified
Journal Article
Open access
PDF file
PPPraveena Paliwal
Praveena Paliwal
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
SBSheetal K. Bhardwaj
Sheetal K. Bhardwaj
VBVinay Bhardwaj
Vinay Bhardwaj
CDChandra Dixit
Chandra Dixit
Ajeet KaushikAjeet Kaushik
Ajeet Kaushik
The outbreak of the COVID-19, a human beta coronavirus severe acute respiratory syndrome (SARS-CoV-2) virus infection, has severely affected the world. The pandemic is not yet in full control due to a lack of rapid diagnostics and therapeutics. This viral infection continues to result in a steadily increasing loss of life, and it has also emerged as a significant global socio-economic burden. As result, it has united many countries for the purposes of exploring molecular biology, biomedical science, and the nanotechnology to manage COVID-19 successfully. As of today, the current priority is to investigate novel therapies of high efficacy and smart diagnostics tools for early-stage disease diagnostics along with monitoring. Keeping these advancement and challenges in mind, this perspective article mainly highlights the contribution and possibilities of bio-nanotechnology to manage the COVID-19 pandemic, even in a personalized manner. Authors also pinpoint barriers to the utilization of current bio-nanotechnology to facilitate a more accurate understanding of COVID-19 and to lead the way toward personalized health and wellness. Furthermore, we follow the discussion of the features and challenges in upcoming bio-nanotechnology approaches for COVID-19 management. In this progressive option report, bio-nanotechnologies that have been enriched with the power of artificial intelligence and optimized at the personalized level have been found to lead to a sustainable treatment and cure strategy at a global population scale.

23 April 2015 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
Saman SargolzaeiSaman Sargolzaei
Saman Sargolzaei
Arman SargolzaeiArman Sargolzaei
Arman Sargolzaei
MCMercedes Cabrerizo
Mercedes Cabrerizo
GCGang Chen
Gang Chen
MGMohammed Goryawala
Mohammed Goryawala
Malek AdjouadiMalek Adjouadi
Malek Adjouadi
Intracranial volume (ICV) is an important normalization measure used in morphometric analyses to correct for head size in studies of Alzheimer Disease (AD). Inaccurate ICV estimation could introduce bias in the outcome. The current study provides a decision aid in defining protocols for ICV estimation in patients with Alzheimer disease in terms of sampling frequencies that can be optimally used on the volumetric MRI data, and the type of software most suitable for use in estimating the ICV measure.